S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
New AI Stock Payouts (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Options Trading Plan–Perfect For Beginners (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Options Trading Plan–Perfect For Beginners (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
New AI Stock Payouts (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Options Trading Plan–Perfect For Beginners (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Options Trading Plan–Perfect For Beginners (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
New AI Stock Payouts (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Options Trading Plan–Perfect For Beginners (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Options Trading Plan–Perfect For Beginners (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
New AI Stock Payouts (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Options Trading Plan–Perfect For Beginners (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Options Trading Plan–Perfect For Beginners (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
OTCMKTS:AMBBY

Ambu A/S (AMBBY) Stock Forecast, Price & News

$11.23
0.00 (0.00%)
(As of 09/25/2023 ET)
Compare
Today's Range
$11.23
$11.23
50-Day Range
$11.12
$15.50
52-Week Range
$8.08
$16.85
Volume
100 shs
Average Volume
883 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

AMBBY stock logo

About Ambu A/S (OTCMKTS:AMBBY) Stock

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

AMBBY Price History

AMBBY Stock News Headlines

Reviewing Biotricity (OTCMKTS:BTCY) & Ambu A/S (OTCMKTS:AMBBY)
INTERIM REPORT FOR Q3 2022/23
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Dr. Abbey S. Hawkins
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
INTERIM REPORT FOR Q2 2022/23 AND THE HALF-YEAR
INTERIM REPORT FOR Q1 2022/23
AMBU CAPITAL MARKETS DAY 2023
ANNUAL RESULTS 2021/22 (EARNINGS RELEASE)
Annual Report 2021/22
Ambu A/S ADR
Ambu A/S (AMBFF) Q3 2022 Earnings Call Transcript
INTERIM REPORT FOR Q3 2021/22
5 European Stocks to Sell Before Recession Starts
See More Headlines
Receive AMBBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ambu A/S and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:AMBBY
CIK
N/A
Fax
N/A
Employees
4,500
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Ms. Britt Meelby Jensen (Age 50)
    Chief Exec. Officer
    Comp: $620.62k
  • Mr. Thomas Frederik Schmidt (Age 52)
    Exec. VP & CFO
    Comp: $580.9k
  • Mr. Thomas Lykke Henriksen (Age 50)
    Head of HR Systems
    Comp: $10.32k
  • Holger Hesse
    Founder
  • Mr. Henrik Ankjær
    Exec. VP of Global Operations
  • Mr. Finn Mohring
    Chief Technology Officer
  • Mr. Nicolai Thomsen
    Director of Investor Relations & Strategic Financial Planning
  • Mikkel Trier Wagner
    Director of Corp. Communications
  • Mr. Bassel Rifai
    Exec. VP, Chief Marketing Officer & Pres APAC
  • Mr. Måns Barsne
    Exec. VP of Global Innovation & Chief Innovation Officer













AMBBY Stock - Frequently Asked Questions

Should I buy or sell Ambu A/S stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ambu A/S in the last twelve months. There are currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AMBBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AMBBY, but not buy additional shares or sell existing shares.
View AMBBY analyst ratings
or view top-rated stocks.

How have AMBBY shares performed in 2023?

Ambu A/S's stock was trading at $12.94 at the start of the year. Since then, AMBBY stock has decreased by 13.2% and is now trading at $11.23.
View the best growth stocks for 2023 here
.

What is Ambu A/S's stock symbol?

Ambu A/S trades on the OTCMKTS under the ticker symbol "AMBBY."

How do I buy shares of Ambu A/S?

Shares of AMBBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ambu A/S's stock price today?

One share of AMBBY stock can currently be purchased for approximately $11.23.

How many employees does Ambu A/S have?

The company employs 4,500 workers across the globe.

How can I contact Ambu A/S?

Ambu A/S's mailing address is Baltorpbakken 13, Ballerup 2750, Denmark. The official website for the company is www.ambu.com. The company can be reached via phone at (457) 225-2000.

This page (OTCMKTS:AMBBY) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -